PrimeRFP SCOUT · Federal Contract Profile

Abbott Rapid Dx North America (P782RNU1NNK3)Federal contracts · 4 recompetes

Abbott Rapid Dx North America holds $42.8M in federal volume across 9,132 award actions, with 10% at Department of Defense (DOD). SCOUT tracks 4 incumbent recompetes — an estimated $1.2M returning to market over the next 24 months (Moderate exposure). Primary work: In-Vitro Diagnostic Substance; Pharmaceutical Preparation (100% prime). Obligations are up 81% year over year.

$42.8M
Federal Volume
4
Recompetes (24mo)
DOD
Top Agency · 10% firm-wide
9132
Award Actions

Choose one — this changes what we ask next

Score my firm against Abbott Rapid Dx North America

Email me when a Abbott Rapid Dx North America recompete window opens.

Data through · refreshed monthly · window Aug 2025 – Aug 2026

Why are you looking at Abbott Rapid Dx North America?

Score my firm against Abbott Rapid Dx North America

Email me when a Abbott Rapid Dx North America recompete window opens.

What they do

Capability

Service lines

IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING · PHARMACEUTICAL PREPARATION MANUFACTURING · ANALYTICAL LABORATORY INSTRUMENT MANUFACTURING

Work mix: 100% prime · 0% sub · primary NAICS 423450 / PSC 6640 LABORATORY EQUIPMENT AND SUPPLIES

Where they win

2 agencies
% of firm-wide obligated ($42.8M) · all agencies · Top 2 shown (11%); remaining ~89% is other agencies.

Recompete exposure: Moderate · 4 in 24mo

Abbott Rapid Dx North America has an estimated $1.2M in contracts returning to market over the next 24 months.

Part of the ABBOTT RAPID DX NORTH AMERICA LLC corporate family · 2 entities
Metrics basis: local_db
Recompete exposure & trajectory

Recompete exposure

Moderate

Abbott Rapid Dx North America has an estimated $1.2M in contracts returning to market over the next 24 months. 3 within 6 months ($809K).

Trajectory
Expanding+81% YoYFY2025 vs FY2024
'23
'24
'25
SCOUT saves the hours of analysis that capture and proposal teams cannot afford to lose by delivering analyzed intelligence. Incumbent history, competitive positioning, and agency buying patterns get synthesized into…
Gwyne Taylor, Tailored Global
Explore another company
Don’t see your company?

Enter your company name and we'll build the page.

Query this company live in SCOUT via MCP — personalized displacement scoring, alerts, and capture workflow. Learn about SCOUT MCP →

Frequently asked questions

What federal contracts does Abbott Rapid Dx North America hold?

Abbott Rapid Dx North America (UEI P782RNU1NNK3) shows $42.8M across 9132 award actions in SCOUT’s public USASpending-backed profile, with Department of Defense (DOD) as the top buying agency. Totals cover federal prime awards ≥$100K in the rolling window.

How much in federal contracts does Abbott Rapid Dx North America have?

Abbott Rapid Dx North America shows $42.8M across 9,132 award actions. SCOUT tracks 4 incumbent recompetes ($1.2M) returning to market in the next 24 months.

Which agencies does Abbott Rapid Dx North America work with?

Abbott Rapid Dx North America’s firm-wide obligated mix is led by Department of Defense (DOD) (10%), Department of State (DOS) (1%).

What is the UEI for Abbott Rapid Dx North America?

The Unique Entity ID (UEI) for Abbott Rapid Dx North America is P782RNU1NNK3.

Does Abbott Rapid Dx North America have contracts coming up for recompete?

Yes — SCOUT tracks 4 incumbent recompetes in the next 24 months (Moderate exposure). Open the recompete section on this page for PIID-level timing.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Sources: USASpending, FPDS, SAM.gov · Data shown is public-record; analysis by PrimeRFP SCOUT. Corpus refreshed Aug 20, 2026. Profile snapshot Aug 19, 2026.
primerfp.com/intel/company/abbott-rapid-dx-north-america-llc